IGC Pharma (IGC) Net Cash Flow (2010 - 2025)
IGC Pharma (IGC) reported Net Cash Flow of $646000.0 for Q3 2025, up 341.95% year-over-year from $146171.2 in Q3 2024, and up 2591.67% quarter-over-quarter from $24000.0 in Q2 2025.
IGC Pharma (IGC) Net Cash Flow (2010 - 2025) Analysis & Trends
IGC Pharma (IGC) has 16 years of Net Cash Flow data on file, last reported at $646000.0 in Q3 2025.
- Net Cash Flow for Q3 2025 came in at $646000.0, up 341.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $670000.0 (up 185.24% YoY), and the FY2026 annual result was -$683000.0, up 13.1% from the prior year.
- Net Cash Flow advanced to $646000.0 in Q3 2025 per IGC's latest filing, from $24000.0 in the prior quarter.
- Over five years, Net Cash Flow peaked at $13.6 million in Q1 2021 and troughed at -$2.5 million in Q4 2021.
- A 5-year average of $12052.6 and a median of -$1.1 million in 2024 frame the typical range for Net Cash Flow.
- On a YoY basis, Net Cash Flow climbed as much as 583.14% in 2021 and fell as far as 1194.24% in 2021.
- A 5-year view of Net Cash Flow shows it stood at -$2.5 million in 2021, then jumped by 32.65% to -$1.7 million in 2022, then gained by 0.96% to -$1.6 million in 2023, then jumped by 34.75% to -$1.1 million in 2024, then soared by 160.04% to $646000.0 in 2025.
- Business Quant data shows IGC's Net Cash Flow at $646000.0 in Q3 2025, $24000.0 in Q2 2025, and -$67000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -2.44 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 664,983.53 |
| 10 | IGC Pharma | 29.33 Mn | 29.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 646,000.00 |
| Sep 30, 2025 | 646,000.00 |
| Jun 30, 2025 | 24,000.00 |
| Jun 30, 2025 | 24,000.00 |
| Mar 31, 2025 | -67,000.00 |
| Mar 31, 2025 | -67,000.00 |
| Dec 31, 2024 | -1.08 Mn |
| Dec 31, 2024 | -1.08 Mn |
| Sep 30, 2024 | -267,000.00 |
| Sep 30, 2024 | -267,000.00 |
| Jun 30, 2024 | 624,000.00 |
| Jun 30, 2024 | 624,000.00 |
| Mar 31, 2024 | -182,000.00 |
| Mar 31, 2024 | -182,000.00 |
| Dec 31, 2023 | -1.65 Mn |
| Dec 31, 2023 | -1.65 Mn |
| Sep 30, 2023 | 1.31 Mn |
| Sep 30, 2023 | 1.31 Mn |
| Jun 30, 2023 | -1.47 Mn |
| Jun 30, 2023 | -1.47 Mn |